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Objectives The number of workers with cancer has 
dramatically increasing worldwide. One of the main 
priorities is to preserve their quality of life and the 
sustainability of social security systems. We have carried 
out this study to assess factors associated with the ability 
to work after cancer. Such insight should help with the 
planning of rehabilitation needs and tailored programmes.
Participants We conducted this register-based cohort 
study using individual data from the Belgian Disability 
Insurance. Data on 15 543 socially insured Belgian people 
who entered into the long-term work disability between 
2007 and 2011 due to cancer were used.
Primary and secondary outcome measures We 
estimated the duration of work disability using Kaplan-
Meier and the cause-specific cumulative incidence of 
ability to work stratified by age, gender, occupational class 
and year of entering the work disability system for 11 
cancer sites using the Fine and Gray model allowing for 
competing risks.
results The overall median time of work disability was 
1.59 years (95% CI 1.52 to 1.66), ranging from 0.75 to 
4.98 years. By the end of follow-up, more than one-third 
of the disabled cancer survivors were able to work (35%). 
While a large proportion of the women were able to work 
at the end of follow-up, the men who were able to work 
could do so sooner. Being women, white collar, young and 
having haematological, male genital or breast cancers 
were factors with the bestlikelihood to be able to return to 
work.
Conclusion Good prognostic factors for the ability to work 
were youth, woman, white collar and having breast, male 
genital or haematological cancers. Reviewing our results 
together with the cancer incidence predictions up to 2025 
offers a high value for social security and rehabilitation 
planning and for ascertaining patients’ perspectives.
bACkgrOund  
The direct and indirect effects of work 
disability represent a significant burden 
for people who are absent due to sickness 
and to their families and their employers.1 
Long-term work disability may lead to social 
exclusion, deprivation or economic insecu-
rity,2 as well as poor health.3 The negative 
impact of work disability on both social and 
health status is of high importance for public 
health,4 but studies identifying those cancer 
survivors who are at risk of experiencing long-
term work disability and identifying the avoid-
able proportion of work disability are lagging 
behind.
Work disability imposes significant costs 
on society5 6 with up to 5% of gross domestic 
product in Organisation for Economic Co-op-
eration and Development (OECD) countries 
being spent on disability benefits.5 In 2010, 
the OECD published a report describing 
the barriers to (re)integration in the labour 
market for people with disability (ie, greater 
competition, more demanding workload and 
work pressure).5 The report also describes the 
strengths and limitations of this study
 ► (Good) External validity: we used a population-
based dataset without loss of follow-up; the external 
validity is therefore largely not limited, and the study 
offers high value (when linked with cancer incidence 
predictions) for the planning of rehabilitation needs 
for patients with cancer up to year 2025.
 ► Use of competing risk analysis: competing risks 
were added to the traditional survival analysis to 
respect the complexity of the outcomes. This is still 
rarely done in disability studies.
 ► Incomplete model: the lack of information on 
treatments and job demands limited the capacity 
of our model to (1) support the identification of a 
precise risk profile and (2) to tailor return-to-work 
interventions.
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underlying social and economic tragedies. As the results 
for Belgium were poor, with a decrease in the number of 
people with disabilities employed over the past decade, 
authorities and social security administrators have been 
looking for measures or interventions to reverse the trend. 
A number of studies have been performed to support the 
authorities, but these are mainly qualitative and are based 
on small samples of cancer survivors.7–13
Insurance medicine researchers and epidemiologists 
acknowledge differences between diagnoses in terms of 
the duration of work disability.14 15 Overall, the leading 
causes of work disability are musculoskeletal disorders 
and mental health problems, which have been widely 
studied.16
In Belgium, cancer is the fifth greatest cause of work 
disability, with 18 462 people on work disability due to 
cancer in 2013 (6.2% of all workers on work disability in 
Belgium)17 (table 1). Each year, more than 25 000 Belgian 
inhabitants of working age (20–64 years) are diagnosed 
with cancer.
Over the last decade, cancer treatments in middle and 
high-income countries have greatly improved, leading 
to increased rates of cancer survival.18 19 Despite these 
improved survival rates, a cancer diagnosis still causes 
great distress among individuals and their relatives20 
and is associated with work disability or death by their 
colleagues and supervisors.7 21–24
This automatic association of cancer with death is 
becoming less and less accurate, however, as was notably 
demonstrated in the study by Dal Maso et al25 that a 
quarter of Italian cancer survivors have reached a death 
rate similar to that of the general population.
Cancer survivors can experience physiological and/or 
psychosocial symptoms due to side effects or long-term 
effects of treatment26 and are more likely to report fair 
or poor health overall in all age groups.27 For these survi-
vors, work can represent a return to health or normality; a 
safeguard of their financial security, self-esteem and social 
contacts.28–33
Many studies have highlighted social inequalities 
in relation to return to work (RTW) among cancer 
survivors34 The well-established relationship between 
socioeconomic position (SEP) and long-term sick-
ness absence predicts that returning to work will be 
more difficult for cancer survivors in manual occupa-
tions.35 36 Previous research has shown that working 
conditions and psychosocial conditions in manual 
occupations act as additional barriers.35 37 38 Alongside 
the impact of working conditions, the unequal use of 
cancer rehabilitation services39 may also lead to social 
inequalities in terms of RTW. It has also been shown 
that cancer survivors with a low SEP more commonly 
become unemployed40 or take early retirement, which 
can act as a substitute for sickness absence benefits or 
unemployment.40–42
the belgian context
In Belgium, cessation of work due to sickness must be 
reported to the employer immediately. The employer 
pays the guaranteed salary for 14 working days for blue-
collar workers (manual workers) and 28 working days for 
white-collar workers (intellectual workers). For self-em-
ployed or unemployed individuals, the social security 
system (SSS) covers salary replacement after 28 working 
days. The absence due to sickness must be confirmed by a 
general practitioner or a specialist doctor.
After the period of guaranteed income from the 
employer, the SSS takes over the provision of a replace-
ment income. The benefits for sickness-related absences 
vary between 40% and 65% of the reference salary, 
depending on the family situation (figure 1).
The SSS distinguishes between short-term and long-
term work disability. Short-term work disability lasts up 
to 1 year, while long-term work disability is for periods 
exceeding 1 year. The division reflects a different evalua-
tion method for assessing the worker’s eligibility for sick-
ness absence benefits as well as the calculation of the level 
of sickness absence benefits.
Table 1 Number of cause-specific disabled workers in Belgium (top five evolution 2007–2013)
Group of diseases 2007 2008 2009 2010 2011 2012 2013




58 032 (26%) 60 595 (26%) 65 146 (27%) 69 583 (27%) 74 192 (28%) 79 643 (28%) 86 071 (29%)
Circulatory diseases 19 372 (9%) 19 216 (8%) 19 427 (8%) 19 571 (8%) 19 549 (7%) 19 772 (7%) 19 963 (7%)
Traumatic injuries 
and poisoning
15 302 (7%) 15 776 (7%) 16 538 (7%) 17 080 (7%) 17 635 (7%) 18 383 (6%) 18 955 (6%)
Tumours* 13 592 (6%) 14 266 (6%) 15 103 (6%) 16 083 (6%) 16 742 (6%) 17 591 (6%) 18 462 (6%)
Others (13 other 
conditions)
43 332 (19%) 44 188 (19%) 45 748 (19%) 47 083 (18%) 48 482 (18%) 49 981 (18%) 51 666 (17%)
Total 223 684 
(100%)
232 153 245 209 257 935 269 499 283 541 299 408
Annual Report National Institute for Health and Disability Insurance, 2014.
*Including cancers and benign tumours.
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Entitlement to long-term sickness absence benefits 
begins as of the second year after stopping work (13th 
month) and continues until the age of retirement, 
with no limit of duration. This applies to employees, 
self-employed and unemployed socially insured Belgian 
citizens. Civil servants (almost 20% of the Belgian work-
force) benefit from a specific social security scheme. In 
Belgium, more than 90% of citizens are socially insured 
and covered by compulsory health insurance.43
There is an important knowledge gap in Belgium 
regarding a quantitative assessment of the impact of 
cancer on work disability. The following aspects need to 
be better understood: how long the work disability lasts, 
how the work disability ends, which workers are more 
at risk and so on. Our research helps to fill this gap. It 
is based on a recent model, developed in 2011 to study 
RTW after cancer,22 which proposes a comprehensive list 
of influencing factors. Among these, we have been able 
to collect and analyse data on the following: age, gender, 
occupational class (OC), site of cancer and work-re-
lated outcomes (ability to work, retirement, death and 
disability).
This study is part of the scientific approach initiated 
in 2012 at the request of the Federal Ministry of Public 
Health and Social Security44 45 to provide evidence and 
support for the decision-making process to improve 
and facilitate the professional reintegration of cancer 
survivors.
Our work reflects research on work disability due to 
cancer. Work disability is defined or measured as a legal 
status based on administrative definitions, that is, eligi-
bility for benefit.
This article describes and discusses the results of a 
population-based cohort study of people with long-term 
cancer-related work disability, that is, receiving sickness 
absence benefits for more than 1 year. We will refer to 
this population below as ‘disabled workers’. They have 
been followed for 3–7 years to measure the outflow from 




We presented the list of data required, the objectives and 
the format in which we planned to publish the results to 
the scientific board of the National Institute for Health 
and Disability Insurance (NIHDI). No ethical or privacy 
issues were identified by the Board, which allowed the 
extraction of the required data and the transfer of the 
coded dataset to the Cancer Centre of the Scientific Insti-
tute of Public Health (IPH). All data are administrative 
data automatically collected by the NIHDI. We therefore 
did not need informed consent from the workers. The 
coded data were transferred to the IPH through Outlook 
and are stored on the local server of the IPH that meets 
data safety and protection standards.
We included all socially insured Belgian people who 
entered into long-term work disability due to cancer 
between 1 January 2007 and 31 December 2011, excluding 
civil servants who are not included in the NIHDI database. 
From the total of 21 701 individuals, 6098 were excluded 
either due to their work disability starting before 1 January 
2007 (and non-equivalent follow-up time) or due to 
inconsistent records (see figure 2). The last update of the 
data was on 31 December 2013, resulting in a maximum 
follow-up of 7 years.
design and statistical analysis
We conducted a register-based cohort study, using data 
from the disability register of the NIHDI. Our research 
had three goals. Our first goal was to measure the dura-
tion of work disability by the year of entry in the work 
disability system. To achieve this first goal, we calculated 
the Kaplan-Meier estimate.
Second, following the taxonomy set out in theories of 
work disability,46 our study aimed to build a prognostic 
model to estimate the subdistribution hazards of each 
event (death, ability to work and retirement) in the pres-
ence of competing risks using the Fine and Gray47 model. 
For each event, the model was built separately for men 
and women, while adjusting for age, year of entry, cancer 
site and OC.
Figure 1 The Belgian social security scheme related to work disability. SSS, social security system.
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A third objective was to investigate social inequalities 
for ability to work among cancer survivors, paying atten-
tion to differences in age, gender and OC and adjusting 
for year of entry. For this, we also used the Fine and Gray 
model, replacing the cancer sites with four categories of 
cancer: those with low,i mediumii and highiii survival rates, 
according to the age-standardised 5-year relative survival 
(ASRS), calculated by the Belgian Cancer Registry.48 
The missing category includes those individuals with a 
i Low survival rates: 'oesophagus', 'stomach', 'colon and rectum', 
'pancreas', 'Other malignant neoplasm (Oth. Mal. Neop.) of digestive 
organs and peritoneum', 'mesothelioma', 'trachea and lung', 'myeloid 
and others', 'CNS', 'Oth. malignancies and undefined sites, invasive'.
ii Medium survival rates: 'lip and oral cavity, nasal cavities, middle ear and 
accessory sinuses, pharynx, larynx', 'non-Hodgkin's disease', 'uterus', 
'cervix', 'ovary', 'Oth. mal. neop. women genitals', 'cervix', 'ovary', 'Oth. 
mal. neop. of women genitals', 'bladder', 'urinary system other than 
bladder', 'bone and connective tissue'.
iii High survival rates: 'Hodgkin disease', 'acute lymphoid leukaemia and 
lymphoid leukaemia, other', 'breast women', 'uterus', 'kidney', 'mela-
noma of the skin', 'thyroid and other endocrine glands'.
cancer site for which the ASRS was not available.iv The 
two rationales behind this approach were as follows: first, 
it generates a parsimonious model (it avoids the lack of 
convergence due to the large size of the data set). Second, 
this approach makes it possible to account for the severity 
of the disease.
For the two first objectives, we used the ‘cmprsk’ 
package of the statistical software R which allows subdis-
tribution analysis of competing risks. For the third objec-
tive, we used the Stata’s V.14 stcrreg package.
Independent prognostic variables
Sociodemographic characteristics included in our study 
were age at entry into the work disability system, gender 
and OC. The age variable was based on the date of birth 
and was further categorised into four groups: 17–39; 
40–49; 50–59 and 60+years. OCs were based on four 
categories: blue-collar workers, white-collar workers, 
iv Missing survival rates: 'benign tumour', 'Mal. neop. of skin other than 
melanoma', 'Oth. malignancies and undefined sites, CIS', 'tumours of 
uncertain and unspecified behaviour'.
Figure 2 Flow chart of the number of workers disabled because of cancer between 2007 and 2011 in Belgium.
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self-employed people and assisting spouses. They were 
recoded into a three-level variable: blue-collar workers, 
white-collar workers and self-employed people.
In total, 39 cancer sites have been identified using the 
‘pathology codes’ transmitted by the NIHDI and regis-
tered by their International Classification of Diseases, 
Ninth Revision (ICD-9) codes (table 2). For the sake of 
comparability, we translated these into ICD-10 codes and 
gathered them into 11 cancer sites (table 2).
The year of entry in the work disability system was a 
continuous variable ranging from 2007 to 2011. We 
decided to recode the year of entry into a two-level vari-
able: 2007–2010 and 2011. This decision is based on an 
exploratory analysis that showed significant difference 
in survival patterns between disability acquired before 
or after 2011 (log-rank test=502, df=1, P value<0.001) 
(figure 3).
Outcome variables: three competing events
The outcome variable is the event that causes the end 
of work disability. We defined three mutually exclusive 
events, that is, competing risks: death, retirement and 
ability to work.
The status retirement indicates that the worker is defin-
itively out of the labour market due to age and will receive 
social benefits until death, while able to work indicates 
that the cancer-disabled worker was recognised by a 
health insurer's doctor as able to work. In practice, this 
might lead to an RTW, to unemployment or to a decision 
to be a stay-at-home spouse.
Those long-term workers with disability who had not 
experienced any event by the end of follow-up, on 31 
December 2013, were administratively censored (38%, 
table 3).
results
description of the study population
No observed workers were lost to follow-up. Table 3 
describes the main characteristics of the work-disabled 
cancer survivors included in the study.
The majority (77%) of the cancer-disabled workers 
were aged 40–59 years.
Women were over-represented (62%), younger at 
entry (median age of 48 vs 53 years for men) and mostly 
white-collar workers (46% vs 21% for men) or blue-
collar workers (43% vs 60%). After 3 years of follow-up, 
the outcome for the majority of cancer-disabled women 
(irrespectively from their year of entry) was disability 
(42.35%), while for most men the outcome was death 
(43.52%).
The most frequent cancer site was breast, representing 
35% (n=5949) of disabled workers, followed by 15% 
(n=2400) of digestive tract cancers and 9% (n=1417) of 
respiratory tract cancers.
Regarding OC, half of the disabled workers were blue-
collar workers, the majority of whom (41.34% of the total) 
were still disabled after 3 years of follow-up. White-collar 
workers (37%) had the shortest median time of work 
disability (1.30 years vs 1.79 years for the others), and 
the majority (40.74%) were able to work after 3 years of 
follow-up. Self-employed disabled workers represented 
13% of the cohort, and the majority (38.82%) were still 
in disability after 3 years of follow-up.
After 3 years of follow-up, 62% of the cohort had expe-
rienced one of the three competing events (29% died, 
1% retired and 32% were able to work). The other 38% 
remained disabled (table 3).
Figures 4–8 show the non-parametric cause-specific 
cumulative incidences of time to ability to work in the 
presence of competing risks. For all prognostic variables, 
the curves show a steep increase in ability to RTW within 
the first 2 years; later, the curves virtually level off.
Figures 9–12 show the box plots of time to any event 
(death, ability to work or retirement) stratified by each 
prognostic variable, respectively.
Younger workers (17–39 years) had the highest rates of 
ability to work at the end of follow-up (figure 5) and rela-
tively short periods of work disability (figure 9), mainly 
due to the ability to work. Older workers presented the 
shortest work disability periods (figure 9), mainly due to 
death or retirement (59.14%, table 3).
Women had higher rates of ability to work compared 
with men (figure 6) but spent longer periods in work 
disability (figure 10). White-collar workers had higher 
rates of work disability and spent less time in it (figure 11). 
Regarding the cancer sites, workers with breast or haema-
tological cancer had the highest rates of ability to work 
by the end of follow-up (figure 8) but the longest periods 
spent on work disability (figure 12). Those with respira-
tory tract, head and neck, digestive or central nervous 
system (CNS) cancers had the lowest rates of ability to 
work (figure 8) and shorter periods of work disability 
(figure 12), mainly due to death.
Prediction patterns of the end of work disability (model 1)
Results in table 4 suggest that good prognostic factors for 
the ability to work for both men and women are disability 
experienced after 2011 and white-collar OC. Regarding 
the 11 cancer sites, men with haematological or genital 
organ cancers are the most likely to be able to work. 
Among women, the cancer sites with the best chance for 
ability to work are haematological and breast.
Concerning deaths among men, disabled workers with 
respiratory tract, CNS, bone and connective tissue cancers 
are most at risk. Among women, those with respiratory 
tract, female genital organs, digestive tract and head and 
neck cancers are most at risk.
social inequalities in the work disability of cancer survivors 
(model 2)
In the second model, we stratify by age and gender and 
allow interactions between both these variables and OC 
and survival categories (table 5). The absence of indi-
viduals in certain age categories entering retirement 
(17–49 years, table 2) leads to a convergence issue when 
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Table 2 The 11 cancer groups used for the analysis
Groups











observed in the 
data




2 Head and neck: lip, oral cavity, nasal 
cavities, middle-ear and accessory 
sinuses, pharynx, larynx
50.0 57.0 Medium 877
3 Digestive tract 22.8 22.7 Low 2400
  Oesophagus 257
  Stomach 218
  Colon and rectum 1479
  Pancreas 209
  Other malignant neoplasms of digestive 
organs and peritoneum
237
4 Respiratory tract 14.6 19.5 Low 1417
  Trachea and lung 1404
  Mesothelioma 13
5 Haematological 1660
  Hodgkin disease 86.1 85.0 High 263
  Non-Hodgkin disease 67.0 68.9 Medium 711
  Acute lymphoid leukaemia and 
lymphoid leukaemia and others
81.3 76.7 High 161
  Myeloid leukaemia and others 38.5 40.6 Low 307
6 Breast 78.2 88.0 High 5511
  Female breast 5494
  Male breast 17
7 Female genital organs 821
  Corpus uterus - Cervix uteri 69.8 Medium 273
  Cervix uteri Corpus uterus 
79.6
High 147
  Ovary Ovary 54.1 Medium 362
  Others 
8 Male genital organs 95.3 — High 486
  Prostate 377 
  Testis 94
  Others 16
9 Urinary tract 388
  Kidney 71.0 0.7 High 147
  Bladder 56.6 49.2 Medium 178
  Others 63
10 CNS 22.7 25.8 Low 709
11 Bone and connective tissue (sarcomas) 61.9 59.7 Medium
Melanoma of the skin 86.2 91.0 High
Malignant neoplasms of skin other than 
melanoma
NA
Thyroid and other endocrine glands 89.3 94.1 High
Continued
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modelling the cause-specific hazard for this type of event 
and this is therefore not reported.
Table 5 shows that, among men, blue-collar and self-em-
ployed workers aged 50–59 years were less likely to be 
able to work compared with white-collar workers. Similar 
results were found for blue-collar women aged 17–39, 
40–49 and 50–59. These results translate into larger social 
inequalities in the 50–59 age group for both men and 
women.
Self-employed men were less likely to be able to work 
than white-collar workers when aged 17–39 or 50–59 and 
similarly for women aged 50–59.
dIsCussIOn
In this study, we aimed to identify the factors that influ-
ence the reason for exiting the long-term work disability 
system and the length of work disability among cancer 
survivors.
To achieve this, we first measured the association 
between the duration of work disability and age, gender, 
OC, the year of entry into the work disability system and 
11 cancer sites. Second, we estimated the distribution of 
three competing reasons for exiting the work disability 
system; and third, we investigated social inequalities in 
work disability among cancer survivors.
As not many of the population-based studies in this field 
include several cancer sites or use competing risk analysis, 
making comparisons is not easy. Moreover, our follow-up 
starts 1 year after the first day of sickness absence, that is, 
we only include long-term disabled workers. However, 
the impact of these determining factors on labour market 
participation has been tested in previous studies.49 
Results indicate that, overall, older age at entry into the 
work disability system and male gender are both factors 
that decrease the chance of being economically active. 
Our results show that an older age (>60 years) increase 
the risk of dying or retiring, and that workers aged 40–49 
were the most likely to remain with disability for a long 
period (table 3). Men did indeed reduce the likelihood 
of being able to work but women experienced longer 
periods within the work disability system overall.
Regarding the cancer sites, we found a strong asso-
ciation between respiratory tract, head and neck and 
digestive tract cancers and death. The first two include 
smoking-related cancer sites,50 which represent major 
sources of work disability and death in the working age 
population.
Other studies have compared different cancer sites 
to assess their association with employment status after 
cancer diagnosis. In line with our results, workers with 
respiratory and female genital cancers present smaller 
proportions of employment than workers with breast or 
haematological cancers, mainly due to poor self-reported 
health status.26 27 51
In line with previous research, blue-collar and self-em-
ployed workers are less likely to be able to work after cancer 
compared with white-collar workers, especially those aged 
50–59 years.26 According to other research, these social 
inequalities could be explained by more demanding 
working conditions,52 later stage of cancer at diagnosis, 
differences in treatment53 and lower participation in 
Groups











observed in the 
data
Other malignancies and undefined sites, 
invasive
51.5 39.1 Medium/low




*Reference: Belgian Cancer Registry. Cancer Survival in Belgium, 2004–2008.
CIS, carcinoma in situ; CNS, central nervous system; NA, not applicable.
Table 2 Continued 
Figure 3 Kaplan-Meier estimator for the time in work 
disability, stratified by the year of entrance into work 
disability.  Ending long-term work disability happens by 
death, retirement or ability to work, whichever occurs first. 
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rehabilitation services39 among blue-collar workers. OC 
is also strongly associated with the income level, which 
may represent an incentive to RTW when it is significantly 
different (higher) than sickness absence benefits.36
A different impact of the OC on the risk of work 
disability according to age and gender has been shown 
in a Norwegian county, where young workers with blue-
collar jobs are more at risk than older men.54 The asso-
ciation between age and RTW has been reported with 





































































































































































































































































Figure 4 Cumulative incidence of ability to work stratified 
by the year of entrance into long-term disability.
Figure 5 Cumulative incidence of ability to work stratified 
by the age at entry into long-term disability.
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found higher age to be associated with later RTW or 
reduced chance of employment.34 Our results show that, 
for Belgian cancer survivors, the opposite is found, with 
a larger impact of OC from the age of 40 years onwards 
compared with younger counterparts.
Demographic changes and the rising retirement age 
will increase the number of disabled workers  and the 
length of work disability. Combined with the effects of the 
economic crisis (ie, greater competition and emphasis 
on maximum performance) this will worsen the situ-
ation if we do not implement measures, interventions 
and rehabilitation programmes to better (re)integrate 
disabled workers  in the labour market.5
The measure introduced by the Belgian government 
by the end of 2010 seems to have had an impact already, 
as the workers who entered the work disability system in 
2011 showed better outcomes than the others. In 2011, 
a new measure was implemented, allowing disabled 
workers to resume work without prior agreement of the 
health insurer's medical advisor.
Further studies need to be carried out in future to 
confirm this trend. However, at the end of follow-up, only 
Figure 6 Cumulative incidence of ability to work stratified 
by gender.
Figure 7 Cumulative incidence of ability to work stratified 
by occupational class.
Figure 8 Cumulative incidence of ability to work stratified 
by cancer site. CIS, carcinoma in situ. CNS, central nervous 
system.
Figure 9 Box plot of time to any event (death, retirement or 
ability to work) stratified by the age at entry into long-term 
disability.
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34.6% of the cancer survivors were able to work and 31% 
were administratively censored, remaining disabled.
Based on our results, key features of (work) rehabili-
tation programmes can be drawn. The non-parametric 
cause-specific cumulative incidence of time to ability to 
work (figure 4) suggests that interventions should be 
planned and implemented within the 2 years after the 
cancer diagnosis. Differences in age and gender imply 
tailoring of and specific attention to the needs of young 
workers and women. The association of the cancer site 
with the length of disability suggests that the awareness 
of oncologists who treat breast cancer, digestive track 
cancers and head and neck cancers, should be raised on 
the RTW and that they need to be involved in the assess-
ment and management of symptoms.
The negative association of being blue collar or self-em-
ployed calls for the revision of employment policies for 
these high-risk groups, with for example, the creation of 
incentives for employers to adjust the working conditions 
of their sick-listed blue-collar workers.
strengths, limitations and need for further research
The main strength of this study is the representativeness 
of the data and the generalisability of our results. We 
included in the analysis all Belgian workers disabled due 
to cancer between 2007 and 2011, excluding civil servants 
and individuals for whom we detected coding errors.
In most work disability studies, survival analyses are 
used to estimate the time to an event of interest. The 
end of work disability is, however, more complex than 
this, and may be caused by multiple factors. Therefore, 
the use of competing risks analysis becomes appropriate 
to avoid overestimating or underestimating the prob-
ability of experiencing each event.55 This model is still 
rarely used in work disability studies and its use should 
be encouraged.
Regarding the objective of predicting disability, the 
two models showed their capacity to and effectiveness in 
predicting the length and the reasons for ending work 
disability among Belgian cancer survivors. Our second 
model presents original findings, using the survival rates 
to identify social inequalities.
Nevertheless, regarding the objective of providing 
insights on the content of work rehabilitation programmes, 
crucial information is lacking: the stage at diagnosis, the 
Figure 10 Box plot of time to any event (death, retirement 
or ability to work) stratified by gender.
Figure 11 Box plot of time to any event (death, retirement 
or ability to work) stratified by occupational class.
Figure 12 Box plot of time to any event (death, retirement 
or ability to work) stratified by cancer site. CIS, carcinoma in 
situ; CNS, central nervous system. 
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type of treatment received and the side and long-term 
effects of the treatment56; the specific occupation and the 
working environment.57 The inclusion of these variables 
in our models would allow a more complex but efficient 
model, explaining the remaining differences that still 
exist among workers of the same age, gender, OC and 
cancer site. This is feasible in the future, for example, by 
linking data from cancer registries to data on employ-
ment and socioeconomic status. Results could be used to 
develop rehabilitation programmes for cancer survivors 
similar to those that already exist in other countries.58–61
While our paper focuses on work disability among 
cancer survivors in Belgium, it is important to realise that 
the methods and principles used are generic and appli-
cable for addressing work disability as a whole. Therefore, 
this report is also relevant for other conditions and SSS. 
This paper contributes towards closing the knowledge gap 
on the transition among cancer survivors from long-term 
work disability to ability to RTW. Linking these important 
results to predictions of cancer incidence should make it 
possible to plan cancer rehabilitation needs and related 
sickness absence benefits.
Table 5 Subdistribution HR based on the Fine and Gray model stratified by age and gender and adjusted for year of entry
Subdistribution HR at the end of follow-up
Men Women
Death Ability to work Death Ability to work
17–39
Survival rate High 1 1 1 1
Medium 1.16 (0.48–2.82) 0.78 (0.47–1.29) 1.69 (1.08–2.65) 0.75 (0.57–0.99)
Low 2.63 (1.21–5.72) 0.33 (0.19–0.60) 2.91 (1.99–4.26) 0.38 (0.27–0.53)
Missing 2.17 (0.88–5.40) 0.50 (0.25–0.98) 1.33 (0.77–2.29) 0.58 (0.42–0.81)
Occupational class White collar 1 1 1 1
Blue collar 0.48 (0.20–1.15) 0.86 (0.58–1.27) 1.41 (1.02–1.93) 0.58 (0.48–0.69)
Self-employed 1.43 (0.53–3.84) 0.48 (0.26–0.87) 1.13 (0.60–2.11) 1.05 (0.81–1.38)
40–49
Survival rate High 1 1 1 1
Medium 1.53 (0.74–3.15) 1.22 (0.66–2.25) 3.19 (2.39–4.27) 0.58 (0.46–0.72)
Low 3.32 (1.67–6.61) 0.63 (0.33–1.20) 5.84 (4.32–7.90) 0.24 (0.17–0.35)
Missing 0.89 (0.32–2.47) 1.69 (0.82–3.50) 2.96 (2.08–4.22) 0.60 (0.46–0.78)
Occupational class White collar 1 1 1 1
Blue collar 1.12 (0.53–2.34) 0.79 (0.42–1.47) 1.42 (1.13–1.80) 0.59 (0.53–0.67)
Self-employed 1.27 (0.47–3.42) 1.74 (0.88–3.43) 0.96 (0.62–1.49) 0.84 (0.70–1)
50–59
Survival rate High 1 1 1 1
Medium 1.39 (0.93–2.10) 0.82 (0.53–1.24) 3.21 (2.53–4.07) 0.55 (0.44–0.70)
Low 3.21 (2.15–4.77) 0.38 (0.24–0.61) 6.01 (4.73–7.64) 0.21 (0.14–0.31)
Missing 1.47 (0.86–2.52) 0.76 (0.42–1.36) 2.22 (1.62–3.04) 0.75 (0.57–0.98)
Occupational class White collar 1 1 1 1
Blue collar 0.88 (0.57–1.34) 0.60 (0.39–0.92) 1.07 (0.86–1.34) 0.75 (0.65–0.86)
Self-employed 0.75 (0.45–1.24) 0.57 (0.33–0.96) 1.34 (0.98–1.83) 0.69 (0.56–0.86)
≥60
Survival rate High 1 1 1 1
Medium 1.13 (0.51–2.52) 2.26 (0.90–5.68) 2.85 (1.52–5.38) 0.91 (0.47–1.76)
Low 3.16 (1.52–6.55) 0.72 (0.25–2.06) 3.92 (1.91–8.03) 0.29 (0.10–0.86)
Missing 2.14 (0.69–6.66 1.21 (0.29–4.99) 2.68 (0.95–7.54) 0.41 (0.09–1.89)
Occupational class White collar 1 1 1 1
Blue collar 1.39 (0.61–3.13) 1.57 (0.60–4.08) 1.06 (0.54–2.09) 0.80 (0.46–1.39)
Self-employed 0.55 (0.23–1.34) 1.19 (0.46–3.10) 1.09 (0.55–2.18) 0.60 (0.32–1.12)
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